Welcome to Correa Research Center
13255 SW 137 AVE #110
Miami, FL 33186
Call Us
(786) 732-4413
Mon - Fri: 9:00 am - 5:00 pm
St - Sun: Closed
Clinical Trials

What Are Clinical Trials?

We take an investigative approach, and we implement it with great accuracy. Results that are critical to the public release of a new medication and the enhancement of patient care can be obtained by Correa Research Center.

What occurs if a volunteer for a clinical trial is accepted? You support the advancement of medicine by identifying and refining therapies for diseases that are already known to exist.

What is the significance of your involvement? You will be essential to the research and development of new medications in the hopes of obtaining precise data to ascertain how these will be distributed to the general population in the future.

Clinical Trial Phases

Phase I

Study Participants: 20 to 100 healthy volunteers or people with the disease/condition.

Length of Study: Several months

Purpose: Safety and dosage

Approximately 70% of drugs move to the next phase

Phase II

Study Participants: Up to several hundred people with the disease/condition.

Length of Study: Several months to 2 years

Purpose: Efficacy and side effects

Approximately 33% of drugs move to the next phase

Phase III

Study Participants: 300 to 3,000 volunteers who have the disease or condition

Length of Study: 1 to 4 years

Purpose: Efficacy and monitoring of adverse reactions

Approximately 25-30% of drugs move to the next phase

Phase IV

Study Participants: Several thousand volunteers who have the disease/condition.

Clinical Trials

Designing Clinical Trials

Researchers design clinical trials to answer specific research questions related to a medical product. These trials follow a specific study plan, called a protocol, that is developed by the researcher or manufacturer. Before a clinical trial begins, researchers review prior information about the drug to develop research questions and objectives. Then, they decide:

  • Who qualifies to participate (selection criteria)
  • How many people will be part of the study
  • How long the study will last
  • Whether there will be a control group and other ways to limit research bias
  • How the drug will be given to patients and at what dosage
  • What assessments will be conducted, when, and what data will be collected
  • How the data will be reviewed and analyzed

For additional information, get in touch with us